GlassScriptPhysician profile
Tracy Robertson
NPI 1033595111
$2,644.87
in general payments reported to CMS, 2019-2025
13 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $405 · 2022: $172 · 2023: $119 · 2024: $1,773 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,405 · Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,405.20 |
| Food and Beverage | $663.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,445.38 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Astrazeneca Pharmaceuticals LP | $362.43 | 2021-2024 | Andexxa |
| Glaxosmithkline, LLC. | $182.08 | 2021-2024 | Nucala |
| Ucb, INC. | $171.73 | 2021-2024 | Briviact |
| Baxter Healthcare | $115.26 | 2022 | |
| Mallinckrodt Hospital Products INC. | $99.99 | 2021 | |
| Chiesi USA, INC. | $91.00 | 2025 | Cleviprex |
| Route 92 Medical, INC. | $69.53 | 2025 | |
| Abbott Laboratories | $37.13 | 2022-2023 | Perclose Proglide |
| Pfizer INC. | $19.49 | 2023 | |
| Irhythm Technologies, INC. | $19.45 | 2024 | Zio Monitor, Zio Xt Patch |
| Zoll Respicardia, INC. | $15.89 | 2024 | Remede System |
| Terumo Medical Corporation | $15.51 | 2025 | Tr Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.